Shinichi Matsumoto Visiting Professor, Department of Surgery Graduate School of Medicine, Kobe University   At the 20th Symposium of the Field-Driven Healthcare Reform Promotion Council, I was given the opportunity to deliver a lecture for the first time in quite some time. I spoke about islet transplantation, a curative treatment for diabetes. I would like to share the content of that lecture through MRIC.   THE ROAD TO TRANSPLANTATION RESEARCH   When I was in the second yea

Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute 10 Years After the Disaster: A New Phase for Community Healthcare Fourteen years have passed since the Great East Japan Earthquake. Iwaki City in Fukushima Prefecture, which felt the dual impact of the tsunami and the nuclear accident, has seen its population dwindle from over 350,000 to approximately 320,000 today—a continuous decline of about 4,500 people every year. It has been seven years si

Tetsuya Tanimoto, MD. Chairman of Accessible Railway Medical Services Tetsuikai Medical Corporation. Director of Navitas Clinic Kawasaki In May, the drug-pricing policy announced by the Trump administration went beyond a simple reduction in U.S. drug prices and took on the nature of a global political and economic strategy. Its impact is expected to ripple across the entire global pharmaceutical system. Behind the policy, which aims to align U.S. drug prices with those of cou

Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute To explain it again, "Chokubi" is a term for doctors who go "straight" or “direct” ( choku ) into aesthetic medicine ( bi ) immediately after finishing their initial clinical residency, without first passing through a university medical department or a general hospital. Reports last year indicated that several hundred doctors annually are choosing this path. I (the author) have been interested i

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Recently, it was announced that the “Enhanced Games” will be held in Las Vegas, USA, in May 2026. Participants may take part as subjects in clinical trials. Events such as sprinting, swimming, and weightlifting will be held, but what is particularly noteworthy is that athletes can choose from three options: 1.     participating naturally without using any drugs, 2.     participating unde

Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute In recent years, the breast cancer field, which the author is responsible for, has seen a continuous succession of new drug developments. In 2024, capivasertib ("Truqap") for hormone receptor-positive breast cancer with specific gene mutations (PIK3CA, AKT1, PTEN) was approved in March, sacituzumab govitecan ("Trodelvy") for triple-negative breast cancer in November, and datopotamab deruxtecan (